IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Expert Opinion on Therapeutic Targets

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

5.14

h-Index

2022-2023

 101

Rank

2022-2023

 1966

SJR

2022-2023

 1.581

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Expert Opinion on Therapeutic Targets
Abbreviation Expert Opin. Ther. Targets
Publication Type Journal
Subject Area, Categories, Scope Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)
h-index 101
Overall Rank/Ranking 1966
SCImago Journal Rank (SJR) 1.581
Impact Score 5.14
Publisher Taylor and Francis Ltd.
Country United Kingdom
ISSN 14728222, 17447631
Best Quartile Q1
Coverage History 1997-2022




Aim and Scope


Expert Opinion on Therapeutic Targets ranks #40 of 216 in the Pharmacology & Pharmacy category in the 2008 ISI Journal Citation Reports.

Expert Opinion on Therapeutic Targets (ISSN 1472-8222 [print], 1744-7631 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on recently identified novel molecular drug targets, providing expert opinion on the scope for future development and impact on drug discovery.


About Expert Opinion on Therapeutic Targets


Expert Opinion on Therapeutic Targets is a journal covering the technologies/fields/categories related to Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1). It is published by Taylor and Francis Ltd.. The overall rank of Expert Opinion on Therapeutic Targets is 1966. According to SCImago Journal Rank (SJR), this journal is ranked 1.581. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 101. The best quartile for this journal is Q1.

The ISSN of Expert Opinion on Therapeutic Targets journal is 14728222, 17447631. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Opinion on Therapeutic Targets is cited by a total of 1594 articles during the last 3 years (Preceding 2022).


Expert Opinion on Therapeutic Targets Impact IF 2022-2023


The Impact IF 2022 of Expert Opinion on Therapeutic Targets is 5.14, which is computed in 2023 as per its definition. Expert Opinion on Therapeutic Targets IF is decreased by a factor of 0.46 and approximate percentage change is -8.21% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Expert Opinion on Therapeutic Targets Impact IF 2023 Prediction


Impact IF 2022 of Expert Opinion on Therapeutic Targets is 5.14. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Expert Opinion on Therapeutic Targets. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 5.14
2021 5.60
2020 5.35
2019 4.71
2018 4.27
2017 4.29
2016 4.53
2015 4.49
2014 4.79

Expert Opinion on Therapeutic Targets h-index


  Table Setting

Expert Opinion on Therapeutic Targets has an h-index of 101. It means 101 articles of this journal have more than 101 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Expert Opinion on Therapeutic Targets ISSN


The ISSN of Expert Opinion on Therapeutic Targets is 14728222, 17447631. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Expert Opinion on Therapeutic Targets Rank and SCImago Journal Rank (SJR)


The overall rank of Expert Opinion on Therapeutic Targets is 1966. According to SCImago Journal Rank (SJR), this journal is ranked 1.581. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Expert Opinion on Therapeutic Targets by Year


Year SJR
2023/2024 Coming Soon
2022 1.581
2021 1.444
2020 1.964
2019 1.699
2018 1.470
2017 1.597
2016 1.765
2015 1.953
2014 1.990

Ranking of Expert Opinion on Therapeutic Targets by Year


Year Ranking
2023/2024 Coming Soon
2022 1966
2021 2235
2020 1354
2019 1778
2018 2330
2017 2062
2016 1764
2015 1511
2014 1410

Expert Opinion on Therapeutic Targets Publisher


Table Setting

Expert Opinion on Therapeutic Targets is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1997-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Expert Opinion on Therapeutic Targets is Expert Opin. Ther. Targets. This abbreviation ('Expert Opin. Ther. Targets') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Expert Opinion on Therapeutic Targets


If your research field is/are related to Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Expert Opinion on Therapeutic Targets?

Expert Opinion on Therapeutic Targets latest impact IF is 5.14. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.60 (2021) and 4.27 (2018), respectively, in the last 9 years. Moreover, its average IS is 4.8 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Expert Opinion on Therapeutic Targets?

The Expert Opinion on Therapeutic Targets has an SJR (SCImago Journal Rank) of 1.581, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.990 in 2014 and the lowest being 1.444 in 2021. Furthermore, the average SJR of the Expert Opinion on Therapeutic Targets over the previous 9-year period stands at 4.8.


What's the latest h-index of the Expert Opinion on Therapeutic Targets?

The latest h-index of the Expert Opinion on Therapeutic Targets is 101.


Who's the publisher of the Expert Opinion on Therapeutic Targets?

The Expert Opinion on Therapeutic Targets is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.


What's the current ranking of the Expert Opinion on Therapeutic Targets?

The Expert Opinion on Therapeutic Targets is currently ranked 1966 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1354 in 2020 and its lowest position of 2330 in 2018.


What's the abbreviation or short name for the Expert Opinion on Therapeutic Targets?

The standard ISO4 abbreviation for the Expert Opinion on Therapeutic Targets is Expert Opin. Ther. Targets.


Is the "Expert Opinion on Therapeutic Targets" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Expert Opinion on Therapeutic Targets is classified as a journal that the Taylor and Francis Ltd. publishes.


What's the scope or major areas of the Expert Opinion on Therapeutic Targets?

The Expert Opinion on Therapeutic Targets encompasses the following areas:

  • Clinical Biochemistry
  • Drug Discovery
  • Molecular Medicine
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Expert Opinion on Therapeutic Targets?

The Expert Opinion on Therapeutic Targets is assigned the following International Standard Serial Numbers (ISSN): 14728222, 17447631.


What's the best quartile of the Expert Opinion on Therapeutic Targets?

The best quartile for the Expert Opinion on Therapeutic Targets is Q1 (2022).


What's the coverage history of the Expert Opinion on Therapeutic Targets?

The Expert Opinion on Therapeutic Targets coverage history can be summarized as follows: 1997-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Proceedings of the International Symposium on Power Semiconductor Devices and ICs conference and proceedings 7015 49 2.14
IEEE/OSA Journal of Display Technology journal 12809 IEEE Computer Society 68 0.00
Archives of Phytopathology and Plant Protection journal 14852 Taylor and Francis Ltd. 29 1.14
Modern Language Journal journal 918 Wiley-Blackwell 103 3.89
Transnational Corporations journal 6120 UNCTAD United Nations Conference on Trade and Development 27 1.92
Libyan Studies journal 16122 Cambridge University Press 8 0.45
Sapporo Medical Journal journal 20468 Cancer Research Institute, Sapporo Medical University 3 0.00
Population Review journal 17841 Sociological Demography Press 13 0.73
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS conference and proceedings 781 Association for Computing Machinery (ACM) 100 8.01
Journal des Professionnels de l'Enfance journal 27577 TPMA 2 0.00

Check complete list




Year wise Impact Score (IS) of Expert Opinion on Therapeutic Targets

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 5.14
2021 5.60
2020 5.35
2019 4.71
2018 4.27
2017 4.29
2016 4.53
2015 4.49
2014 4.79



Top Journals/Conferences in Clinical Biochemistry

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Cell Chemical Biology
Elsevier Inc. | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Redox Biology
Elsevier BV | Netherlands

Biomarker Research
BioMed Central Ltd. | United Kingdom

Angiogenesis
Springer Netherlands | Netherlands

Critical Reviews in Clinical Laboratory Sciences
Informa Healthcare | United Kingdom

American Journal of Respiratory Cell and Molecular Biology
American Thoracic Society | United States

Journal of Clinical Endocrinology and Metabolism
Endocrine Society | United States

See All

Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All